Association of Markers of Bone Mineral Disease and Left Ventricular Hypertrophy in Patients of Chronic Kidney Disease

Background. Chronic kidney disease (CKD) is an epidemic health problem responsible for an increase in morbidity and mortality secondary to various complications, especially cardiovascular events. Previous studies have suggested that biochemical markers of metabolic bone disease (MBD) are associated...

詳細記述

書誌詳細

出版年:	Acta Medica Bulgarica
主要な著者:	Aggarwal H. K., Jain D., Kaur S., Dahiya S., Harish P., Kumar A.
フォーマット:	論文
言語:	英語
出版事項:	Sciendo 2024-09-01
主題:	chronic kidney disease-metabolic bone disease left ventricular hypertrophy fibroblast growth factor-23
オンライン･アクセス:	https://doi.org/10.2478/amb-2024-0038